Mission and Goal


The fundamental mission of KoDiscovery is to complete the necessary research, including human clinical trials, to make 3-Bromopyruvate (3BP) therapy available for all people with cancer. To further define and differentiate her discovery, she has designated her patented formulation, now 20 years in development, as KoDiscovery Anti-cancer, Anti-infection Therapeutics, or KAAT™. Our broader mission, therefore,  is to support the development of treatments and cures for multiple types of cancer, neurological diseases, and other devastating disorders for which no effective therapies are yet known. Ultimately, our mission is to provide relief to those suffering from any health issue, including malnutrition, illness, poverty, lack of basic needs, and other health and human needs that are prevalent around the world.


The goal of KoDiscovery is to become a world leader in the research and delivery of innovative therapies in the field of advanced metabolic and cellular diseases. We will work diligently to ensure that all people with cancer and neurodegenerative diseases have access to the best medical treatments available.  

Cancer is a terrible disease that touches us all. We ask that you remember that while Dr. Ko is a passionate and dedicated research scientist, she is not a practicing medical physician. Because of this, she is unable to currently treat patients on an individual basis. By allowing her to focus her efforts, perfect her research, and make 3BP available for all, we will be supporting her goal of successfully treating cancer and bringing this great gift to humanity as quickly as possible.

The information provided on this website by KoDiscovery, LLC does not constitute a medical recommendation.

It is intended for informational purposes only, and no claims, either real or implied, are being made. 

701 East Pratt Street, Lab 4023, Baltimore, MD  21202

Phone: 443-769-1741

No information from this website can be copied or reproduced without the expressed consent of KoDiscovery

©2021 by KoDiscovery, LLC